Navigation Links
Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc.
Date:8/20/2008

Licensee of Blue Cross/Blue Shield in fourteen states establishes

guidelines for use of Trofile

SOUTH SAN FRANCISCO, Calif., Aug. 20 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that Wellpoint, Inc. has established a national Medical Policy Guideline for Monogram's Trofile Assay.

Wellpoint's guidelines provide that HIV tropism testing with Trofile is considered medically necessary for selecting individuals for treatment with CCR5 antagonists (i.e. Selzentry(TM)) for patients who have experienced virologic failure during antiretroviral treatment regimens and who have evidence of ongoing HIV-1 viral replication. Further, these guidelines confirm that Trofile is the only assay approved by Wellpoint for determining coreceptor tropism. Wellpoint has developed medical policies and guidelines that serve as some of the guidelines for coverage decisions by individual plans.

"Through its Blue Cross and Blue Shield plans, Wellpoint is one of the largest private healthcare payers in the U.S. and covers almost 35 million lives throughout its networks," said William Welch, Monogram's chief commercial officer. "Many of the individual Blue Cross and Blue Shield plans have been providing coverage for Trofile and we are pleased to see this guideline established at the national level."

Wellpoint, Inc. (formerly Anthem, Inc.) is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent health benefit plans and serves as the Blue Cross and/or Blue Shield licensee in: California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia and Wisconsin. Many of these indi
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... (PRWEB) December 23, 2014 “Preparative ... Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, ... Food & Agriculture) - Forecasts to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ...
(Date:12/24/2014)... Earlier this year in a June 24 international conference presentation, ... Technology Center, LLC ( ASCTC ) focused attention on an ... stem cells. His title “Asymmetric Self-Renewal by Distributed Stem ... the essence of his message to congress participants. He ...
(Date:12/24/2014)... 23, 2014 On Friday, December 19, ... Omnibus and Continuing Resolution Appropriations Act of 2015, which ... to receive funding through the Congressionally Directed Medical Research ... The Hydrocephalus Association (HA), working in conjunction with its ...
(Date:12/24/2014)... 23, 2014 The report provides ... definition, classification, application and industry overview. This report ... cost structure. Production is separated by regions, technology ... materials, equipment, downstream client survey, marketing channels, industry ...
Breaking Biology Technology:Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... ... addition to the traditional pin connection, Tekscan is now offering a lower-cost termination method to ... , ... 30, 2010 -- Tekscan, Inc. announces a new lower-cost connection option for its custom ...
... ... the effect of HGH on athletes and other users sports performance , ... Copenhagen, Denmark (PRWEB) June 30, 2010 -- ... improve a sportsman’s physical performance., , ,However, few researchers from Denmark revealed that the level ...
... taken the first steps toward reducing the size and ... frequency spectrum. By combining a detector and laser ... the researchers rendered unnecessary the precision alignment of optical ... detector. The new solid-state system puts to use ...
Cached Biology Technology:Lower-Cost ZIF and LIF-Compatible Connection Option for Tekscan Custom Force Sensors 2Recent Study Reports Reveals that HGH May Aid Performance 2Sandia Labs reports first monolithic terahertz solid-state transceiver 2
(Date:12/17/2014)... and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has announced ... 2015-2019" report to their offering. ... upcoming in this market is the increasing demand for ... recording of patient data for quick and correct diagnosis ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in the ... One major trend emerging in this market is ... is important to upgrade biometric solutions to the latest ...
(Date:12/11/2014)... ST. PAUL, Minn. , Dec. 10, 2014 ... wireless physiologic monitoring, has released a new series ... needs of preclinical toxicology researchers. M series, part ... help toxicologists collect the best possible physiologic data ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... SecurePad with Fingerprint Sensor Recognized in the ... Enabling Technologies Product Category, ... SYNA ), a leading developer of human interface ... that,its SecurePad(TM) solution has been selected as a CES ...
... Cranberry sauce is not the star of the traditional ... benefits, the lowly condiment takes center stage. In fact, ... compounds in cranberries are able to alter E. coli ... illnesses (from kidney infections to gastroenteritis to tooth decay), ...
... A major study that will provide a new window ... by the La Jolla Institute for Allergy & Immunology ... five-year study, funded by the National Institute of Allergy ... of Health, could lead to revolutionary new approaches for ...
Cached Biology News:Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree 2Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree 3Cranberry sauce: good for what ails you 2Cranberry sauce: good for what ails you 3NIH selects LIAI for major study on allergy molecular causes and possible treatments 2NIH selects LIAI for major study on allergy molecular causes and possible treatments 3NIH selects LIAI for major study on allergy molecular causes and possible treatments 4
...
... solution has effect on enhancing an antigen-antibody ... than the one obtained by conventional methods. ... antibody used and exposure time in fluorescence/luminescence ... with high S/N ratio and low background. ...
... this enzyme exists predominantly as XDH which ... a critical plasma antioxidant. During ischemia, ... radical producing XO by oxidation of essential ... cleavage of the amino-terminus. AO has ...
... 2 bridges the gap between the 500 ... device combines the speed of the classic ... membrane area for superior recoveries from very ... of PES, Cellulose Triacetate membranes, Vivaspin 2 ...
Biology Products: